Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Huttly

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Prenatal Diagnosis|December 11, 1999
Validation of risk estimation using the quadruple test in prenatal screening for Down syndromeN J Wald, W J Huttly
Prenatal Diagnosis|September 22, 1998
The pattern of maternal serum inhibin-A concentrations in the second trimester of pregnancyH C Watt, N J Wald, W J Huttly
Journal of Medical Screening|April 2, 2010
Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndromeJ P Bestwick, W J Huttly, N J Wald
Journal of Medical Screening|April 21, 2017
Pregnancy-associated plasma protein-A truncation limits in antenatal screening for trisomy 18J P Bestwick, W J Huttly, N J Wald
Journal of Medical Screening|March 21, 2013
Improvements in antenatal screening for Down's syndromeN J Wald, J P Bestwick, W J Huttly
Prenatal Diagnosis|October 16, 1999
Inhibin-A regressionH C Watt, N J Wald, W J Huttly
Lancet (London, England)|October 16, 1999
Down's syndrome screening in the UK in 1998N J Wald, W J Huttly, C F Hennessy
BMJ (Clinical Research Ed.)|December 3, 1999
Folic acid supplementation before pregnancy remains inadequateW J Huttly, N J Wald, J C Walters
Journal of Medical Screening|April 2, 2010
Distribution of nuchal translucency in antenatal screening for Down's syndromeJ P Bestwick, W J Huttly, N J Wald
British Journal of Obstetrics and Gynaecology|December 28, 1999
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screeningN J Wald, N White, J K Morris, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Prenatal Diagnosis|December 11, 1999
Validation of risk estimation using the quadruple test in prenatal screening for Down syndromeN J Wald, W J Huttly
Prenatal Diagnosis|September 22, 1998
The pattern of maternal serum inhibin-A concentrations in the second trimester of pregnancyH C Watt, N J Wald, W J Huttly
Journal of Medical Screening|April 2, 2010
Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndromeJ P Bestwick, W J Huttly, N J Wald
Journal of Medical Screening|April 21, 2017
Pregnancy-associated plasma protein-A truncation limits in antenatal screening for trisomy 18J P Bestwick, W J Huttly, N J Wald
Journal of Medical Screening|March 21, 2013
Improvements in antenatal screening for Down's syndromeN J Wald, J P Bestwick, W J Huttly
Prenatal Diagnosis|October 16, 1999
Inhibin-A regressionH C Watt, N J Wald, W J Huttly
Lancet (London, England)|October 16, 1999
Down's syndrome screening in the UK in 1998N J Wald, W J Huttly, C F Hennessy
BMJ (Clinical Research Ed.)|December 3, 1999
Folic acid supplementation before pregnancy remains inadequateW J Huttly, N J Wald, J C Walters
Journal of Medical Screening|April 2, 2010
Distribution of nuchal translucency in antenatal screening for Down's syndromeJ P Bestwick, W J Huttly, N J Wald
British Journal of Obstetrics and Gynaecology|December 28, 1999
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screeningN J Wald, N White, J K Morris, et al.
Pageof 2